Poor performance of FIB-4 in elderly individuals at risk for chronic liver disease - implications for the clinical utility of the EASL NIT guideline

J Hepatol. 2022 Jan;76(1):245-246. doi: 10.1016/j.jhep.2021.08.017. Epub 2021 Aug 28.

Authors

Laurens A van Kleef¹, Milan J Sonneveld¹, Robert A de Man¹, Robert J de Knegt²

Affiliations

¹ Department of Gastroenterology and Hepatology, Erasmus MC University Medical Centre, Rotterdam, The Netherlands.
² Department of Gastroenterology and Hepatology, Erasmus MC University Medical Centre, Rotterdam, The Netherlands. Electronic address: r.deknegt@erasmusmc.nl.

PMID: 34461208
DOI: 10.1016/j.jhep.2021.08.017

No abstract available

Keywords: FIB-4; chronic liver disease; epidemiology; fibrosis; liver stiffness; non-invasive tests.

Publication types

Letter
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Aged
Humans
Liver Cirrhosis* / diagnosis
Non-alcoholic Fatty Liver Disease*